IBM’s AI Paradox: When the Boom Itself Became the Problem
Published on 07/25/2026 at 19:11 | Redaktion boerse-global.de
The numbers tell a brutal story. IBM shares closed at €188.38 on Friday, a 3.74 percent gain that looks more like a gasp for air than a recovery. Behind that modest bounce sits a 30-day decline of 18.63 percent and a year-to-date loss of 27.52 percent. The stock now trades roughly 36 percent below its 52-week high of €292.85, set just seven weeks ago on June 1.
What makes this sell-off remarkable isn’t just its severity — it was the worst single-day plunge in IBM’s 115-year history — but the mechanism behind it. The very AI boom that CEO Arvind Krishna has bet his turnaround on is cannibalizing the company’s core profit centers.
When AI Eats Its Own
On July 14, IBM blindsided the market with a preliminary profit warning. The stock cratered 25 percent in a single session. The explanation had an almost ironic twist: it wasn’t weak AI demand that hurt IBM, but the AI boom itself.
Krishna told investors that customers had shifted their quarterly budgets in the final weeks of June, scrambling to secure servers, storage, and memory chips before those scarce components became more expensive. The scale of that reallocation caught management flat-footed.
Should investors sell immediately? Or is it worth buying IBM?
The official second-quarter report on July 22 confirmed the damage. Adjusted earnings came in at $2.93 per share, missing the $2.97 consensus. Revenue of $17.16 billion fell short of the $17.58 billion forecast, and net income dropped to $2.17 billion year-over-year. The infrastructure segment bore the brunt, shrinking 7 percent to $3.84 billion, with Z-mainframe sales collapsing 42 percent.
IBM responded by trimming its 2026 growth outlook to 4-5 percent at constant currency, down from the “over 5 percent” target set in April.
Analysts describe a company caught in a pincer movement. Corporate clients are pouring money into AI infrastructure, and that cash is coming straight out of budgets for software, consulting, and mainframe upgrades — historically the heart of IBM’s profitability. One analyst noted that companies are deferring mainframe refreshes, an unusual move for what is typically considered mission-critical infrastructure. A second observer pointed out that the pain is compounded: hardware weakness drags software revenue down with it, because mainframe sales traditionally trigger software license purchases.
The Bounce That Isn’t a Turnaround
Friday’s gain of 3.74 percent is best understood as a technical reaction, not a conviction rally. The stock had touched a 52-week low of €175.14 just two days earlier. The 14-day relative strength index sits at 35.5, a level that has historically preceded short-term stabilization. But the shares remain well below both their 50-day moving average of €228.64 and their 200-day average of €233.84 — a textbook bearish configuration.
Annualized 30-day volatility stands at nearly 85 percent, signaling that the market is still searching for a fair price rather than settling into a calm assessment. The Friday bounce looks more like short-covering after an overextended sell-off than a wave of fresh institutional buying.
Not everyone on Wall Street reads existential danger into the rout. Kirk Materne of Evercore ISI argues the sell-off was overdone as a signal of broad software-sector weakness, interpreting it instead as a company-specific concern. The bright spots in the quarterly report support that milder reading: software revenue rose 5 percent to $7.76 billion, Red Hat grew 11 percent, data software jumped 19 percent, and distributed infrastructure climbed 37 percent, partially offsetting the mainframe collapse.
The Cash Flow Anchor and the Quantum Promise
CFO Kavanaugh pushed back against fears that customers are abandoning the mainframe platform, insisting there are “no signs that customers are moving away from mainframe” and forecasting “significant strength in this program in the second half of the year.”
IBM at a turning point? This analysis reveals what investors need to know now.
The analyst community remains deeply split. While Argus slashed its price target, other houses held their ground — an unusual divergence that underscores how uncertain the near-term outlook has become. The average analyst target of €231.11 implies roughly 22.7 percent upside from Friday’s close, a tempting entry point for value-oriented investors. But IBM has looked “cheap” multiple times during this sell-off without forming a durable bottom.
The longer-term thesis still rests on Krishna’s bet that IBM sits at the intersection of legacy systems and next-generation computing — cloud, AI, and eventually quantum. The quantum-computing ambitions and the much-touted AI order book remain part of the investment narrative. In the near term, however, they generate no cash flow, and July demonstrated how harshly the market punishes earnings misses.
The Unanswered Question
IBM’s dilemma offers a cautionary tale for the entire enterprise-software industry. What happens when the AI investment cycle becomes so intense that it consumes the very spending patterns companies were counting on to fund their own AI transformation? Krishna’s wager was always that IBM would serve as the bridge between old systems and new. This quarter showed that a bridge can just as easily become a bottleneck.
Whether the deferred deals are actually closed later this year, as management promises, or whether a more permanent shift in corporate budgets away from IBM’s traditional strengths is underway — that is precisely what the market is pricing in, hour by hour. The volatile chart pattern reflects how unresolved that verdict remains. For patient, valuation-focused investors, the gap to the average price target offers a plausible recovery scenario. For anyone waiting for a confirmed trend reversal, the recent string of sell-offs argues for treating short-term strength with skepticism rather than conviction.
Ad
IBM Stock: New Analysis - 25 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
